They also revealed that treatment with recombinant erythroid differentiation regulator 1 (Erdr1), a negatively regulated conserved factor of IL-18, resulted in significant improvement in a rosacea-like BALB/c mouse model and downregulation of IL-18. Here, IL18 is linked to rosacea.